Valbenazine ( DrugBank: Valbenazine )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
8ハンチントン病2

8. ハンチントン病


臨床試験数 : 242 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04400331
(ClinicalTrials.gov)
September 18, 202019/5/2020Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington DiseaseOpen-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington DiseaseChorea, HuntingtonDrug: ValbenazineNeurocrine BiosciencesHuntington Study GroupRecruiting18 Years75 YearsAll150Phase 3United States;Canada
2NCT04102579
(ClinicalTrials.gov)
November 13, 201923/9/2019Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington DiseaseA Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington DiseaseChorea, HuntingtonDrug: Valbenazine;Drug: PlaceboNeurocrine BiosciencesHuntington Study GroupCompleted18 Years75 YearsAll128Phase 3United States;Canada